Cardiol Therapeutics CRDL
NASDAQ CRDL
$1.17 +0.02 (+1.74%)
At close: Oct 21, 2026 · 4:00 PM EDT

Cardiol Therapeutics (CRDL) Other financing activities (2020 - 2026)

Updated

Cardiol Therapeutics' Other financing activities was -$901,572 in Q1 2026.

Analysis

Cardiol Therapeutics (CRDL) Other financing activities (2020 - 2026) Analysis & Trends

For FY2025, Other financing activities at Cardiol Therapeutics came in at -$341,419.

  • In earlier years, Other financing activities was -$1.94 million in FY2024 and -$4.18 million in FY2021.
  • The Q1 2026 figure marks the lowest quarterly Other financing activities since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Cardiol Therapeutics 102.21 Mn 40.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -901,571.69
Dec 31, 2021 -3.11 Mn
Dec 31, 2020 -38,714.78
API Access

Cardiol Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=CRDL&period=max&api_key=YOUR_API_KEY